Tulavi Therapeutics
John brings 40 years of successful financial leadership in the medical technology field. Previously, he was a Co-Founder and CFO of Imperative Care, Inc., a company focused on developing the next generation of stroke care across the entire patient journey. He also served as CFO at Apama Medical, an atrial fibrillation company (acquired by Boston Scientific Corporation, NYSE: BSX); Access Closure, Inc., a leading player in the vascular closure space (acquired by Cardinal Health in 2014) and Acologix, Inc., a biotechnology company focused on osteo-renal diseases. John spent 16 years at Ernst & Young LLP where he was a Partner and served as Director of the Pacific Northwest Life Science Practice. John currently serves as a senior advisor to Imperative Care, Inc. and to Kandu Health, a digital health company focused on empowering stroke survivors.
This person is not in the org chart
This person is not in any offices
Tulavi Therapeutics
1 followers
Tulavi is a biomedical company dedicated to making better nerve care more accessible. By engineering simple, elegant solutions to restore nerve balance, Tulavi strives to ensure that caregivers have access to effective, easy-to-use solutions that equip them to proactively prevent nerve pain, promote nerve regeneration and provide a higher standard of patient nerve care.